BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Anti CD3 Monoclonal Antibody Market Opportunity Outlook

  In recent years, the field of immunotherapy has emerged as a groundbreaking approach in the treatment of various diseases, particularly in the realm of autoimmune disorders and cancer.

  May 23, 2024

   · 

  4 min read
• Genetown

  Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea

  Apnimed, Inc. announced a series of five data presentations and a dinner symposium at the SLEEP 2024 annual meeting.

  May 23, 2024

   · 

  8 min read
• Annual General Meeting in Cantargia AB (publ) - May 23, 2024

  Cantargia’s Annual General Meeting on 23 May 2024 resolved in accordance with the following.

  May 23, 2024

   · 

  3 min read
• U.S. Biotechnology Instruments Market Size to Reach USD 49.11 Bn by 2033

  According to latest study, the U.S. biotechnology instruments market size is calculated at USD 36.16 billion for 2024 and is expected to reach around USD 49.11 billion by 2033, growing at a CAGR of 3.46% from 2024 to 2033.

  May 23, 2024

   · 

  1 min read
• BioMidwest

  Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)

  Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.

  May 23, 2024

   · 

  3 min read
• Drug Development

  Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

  Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd., announced encouraging initial findings from an ongoing Phase 1 clinical trial.

  May 23, 2024

   · 

  9 min read
• BioMidwest

  Medline introduces high-efficiency medication delivery system to respiratory portfolio

  Medline announced the latest addition to its respiratory care portfolio, the Hudson RCI TurboMist small volume nebulizer.

  May 23, 2024

   · 

  3 min read
• Brainomix Showcases Growing Evidence for its Novel AI-Based Imaging Biomarkers in Lung Fibrosis

  Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, announced a series of new studies that were presented this week at the American Thoracic Society (ATS) Conference in San Diego.

  May 23, 2024

   · 

  3 min read
• Deals

  AbbVie Completes Acquisition of Landos Biopharma

  AbbVie announced that it has completed its acquisition of Landos Biopharma, Inc.

  May 23, 2024

   · 

  4 min read
• Business

  ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

  ONWARD Medical N.V., a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury, provided a Q1 2024 business update.

  May 23, 2024

   · 

  7 min read